A Problematic Test of the Kin Selection Hypothesis Among the Urak-Lawoi of Ko Lipe, Thailand: Commentary on Camperio Ciani, Battaglia, and Liotta (2015)

Camperio Ciani et al. argued that the Urak-Lawoi people of Ko Lipe island live in a ‘‘traditional,’’ ‘‘subsistence primitive society’’ reminiscent of the ‘‘ancestral’’ human past and that their socio-cultural situation is ‘‘remarkably similar’’ to Samoa. On this basis, they asserted that the Ko Lipe Urak-Lawoi are an appropriate population for determining the role that kin selection played in the evolution of male androphilia. The purpose of this commentary is to outline some of our concerns with this characterization and with the statistical analyses conducted by Camperio Ciani et al. in their study of the Urak-Lawoi

A Problematic Test of the Kin Selection Hypothesis Among the Urak-Lawoi of Ko Lipe, Thailand: Commentary on Camperio Ciani, Battaglia, and Liotta (2015)

Camperio Ciani et al. argued that the Urak-Lawoi people of Ko Lipe island live in a ‘‘traditional,’’ ‘‘subsistence primitive society’’ reminiscent of the ‘‘ancestral’’ human past and that their socio-cultural situation is ‘‘remarkably similar’’ to Samoa. On this basis, they asserted that the Ko Lipe Urak-Lawoi are an appropriate population for determining the role that kin selection played in the evolution of male androphilia. The purpose of this commentary is to outline some of our concerns with this characterization and with the statistical analyses conducted by Camperio Ciani et al. in their study of the Urak-Lawoi

Offspring Production among the Extended Relatives of Samoan Men and Fa'afafine

Androphilia refers to sexual attraction to adult males, whereas gynephilia refers to sexual attraction to adult females. Male androphilia is an evolutionary paradox. Its development is at least partially influenced by genetic factors, yet male androphiles exhibit lower reproductive output, thus raising the question of how genetic factors underlying its development persist. The sexual antagonism hypothesis posits that the fitness costs associated with genetic factors underlying male androphilia are offset because these same factors lead to elevated reproduction on the part of the female relatives of androphilic males. Western samples drawn from low fertility populations have yielded inconsistent results when testing this hypothesis. Some studies documented elevated reproduction among the matrilineal female kin of androphilic males, whereas others found such effects in the paternal line. Samoa is a high-fertility population in which individuals reproduce closer to their maximum capacities. This study compared the reproductive output of the paternal and maternal line grandmothers, aunts, and uncles of 86 Samoan androphilic males, known locally as fa'afafine, and 86 Samoan gynephilic males. Reproductive output was elevated in the paternal and maternal line grandmothers, but not aunts or uncles, of fa'afafine. These findings are consistent with the sexual antagonism hypothesis and suggest that male androphilia is associated with elevated reproduction among extended relatives in both the maternal and paternal line. Discussion focuses on how this study, in conjunction with the broader literature, informs various models for the evolution of male androphilia via elevated reproduction on the part of female kin

Sexual adaptation: is female-male mounting a supernormal courtship display in Japanese macaques?

Accepted author manuscriptWe analysed heterosexual consortships in a free-ranging group of Japanese macaques in which adult females routinely perform female-to-male mounting (FMM). We tested whether FMM is more efficient (i.e., a “supernormal courtship” behavioral pattern) than species-typical female-to-male sexual solicitations (FMSS) at prompting subsequent male-to-female mounts (MFM). In a context of high femalefemale competition for male mates, we found that (1) FMM functioned to focus the male consort partner’s attention as efficiently as FMSS and prevented him from moving away, and (2) FMM was more efficient than species-typical FMSS at expediting MFM (i.e., the most fitness-enhancing sexual behavior of a mating sequence). We concluded that FMM could be considered a supernormal courtship behavioral pattern in adult female Japanese macaques. This population-specific sexual adaptation may result from a combination of favorable socio-demographic conditions. This study has implications for the evolutionary history of non-conceptive mounting patterns in Japanese macaques and non-conceptive sexuality in humans

A dose-finding study of carboplatin–epirubicin–docetaxel in advanced epithelial ovarian cancer

The docetaxel–carboplatin combination is active and well tolerated in patients with epithelial ovarian cancer. We added epirubicin to this combination to investigate additional benefits of anthracyclines in epithelial ovarian cancer. Twenty-one patients, FIGO Ic-IV, performance status 0–1, were treated in four dose cohorts. Docetaxel was fixed at 75 mg m−2, carboplatin doses were AUC 4–5 and epirubicin doses were 50–60 mg m−2. Drugs were given on day 1, every 3 weeks, except in cohort 3, where epirubicin was given on day 8. Dexamethasone was given prophylactically. One dose-limiting toxicity occurred in cohorts 1, 2 and 4, two occurred in cohort 3. Complicated neutropenia occurred in two patients in cohorts 1 and 2 and one patient in cohorts 3 and 4. Two patients experienced grade III diarrhoea or stomatitis in cohort 1 and two in cohort 3. There were no treatment-related deaths. Grade II sensory neuropathy occurred in one patient. No cardiac toxicity or significant oedema was observed. The overall response rate was 36%, and 62% were CA125 responders. The predefined maximum tolerated dose was exceeded in cohort 3. The cohort 4 dose level (epirubicin 50 mg m−2, carboplatin AUC 4, docetaxel 75 mg m−2), warrants further study

Inter-group variation in non-conceptive sexual activity in female Japanese macaques: could it be cultural?

Open access distributed under the Creative Commons Attribution 3.0 License.We compared two non-conceptive sexual behavioral patterns (female-male mounting – FMM – and female-female mounting – FFM) across four free-ranging groups of Japanese macaques (Macaca fuscata) living at three different field sites in Japan (Arashiyama, Minoo, and Jigokudani). We found marked inter-group differences and covariation in the frequency and form of FMM and FFM. This result supports the view that FMM and FFM in Japanese macaques are developmentally and evolutionarily linked. The customary occurrence, high prevalence, and great diversity of FMM and FFM at Arashiyama may be the result of combined favorable socio-demographic conditions, namely few resident males, most of them being old, sexually under-motivated, and less aggressive and controlling than the average male Japanese macaques. We suggest that FMM and FFM may be cultural sexual practices in the Arashiyama-E group. In most other populations, all the aforementioned favorable sociodemographic conditions are not met, and although female mounting may occasionally be expressed by several group members, it does not reach the group-level tradition status. Our cultural interpretation of female mounting in Japanese macaques is consistent with evidence of the social transmission of courtship behaviors and mating preferences in various animal taxa, including nonhuman primates and humans. Our study may have implications for the evolution of non-conceptive sexuality in humans, including sexual fluidity in women.Ye

Familial Patterning and Prevalence of Male Androphilia among Istmo Zapotec men and muxes

peer reviewe

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

The feasibility of sequential carboplatin followed by docetaxel-based therapy for untreated ovarian cancer was determined. Patients received four q3w cycles of carboplatin AUC 7, then four q3w cycles of either docetaxel 100 mg m−2 (day 1) (arm A); docetaxel 75 mg m−2 (day 8) and gemcitabine 1250 mg m−2 (days 1,8) (arm B) or docetaxel 25 mg m−2 and gemcitabine 800 mg m−2 (both given weekly (days 1,8,15)) (arm C). A total of 44 patients were randomised to each treatment arm. None of the arms demonstrated an eight cycle completion rate (70.5/72.7/45.5% in arms A/B/C, respectively), which was statistically greater than 60% (P=0.102, P=0.056, P=0.982) which was our formal feasibility criteria, although only the completion rate in arm C was clearly worse than this level. The overall response rate (ORR) after carboplatin was 65.7% in 70 evaluable patients. In evaluable patients, ORRs after docetaxel-based cycles were: arm A 84.0% (21 out of 25); arm B 77.3% (17 out of 22); arm C 69.6% (16 out of 23). At follow-up (median 30 months), median progression-free survival times were: arm A 15.5 months (95% CI: 10.5–20.6); arm B 18.1 months (95% CI: 15.9–20.3); arm C, 13.7 months (95% CI: 12.8–14.6). Neutropenia was the predominant grade 3–4 haematological toxicity: 77.8/85.7/54.4% in arms A/B/C, respectively. Dyspnoea was markedly increased in both gemcitabine-containing arms (P=0.001) but was worse in arm C. Although just failing to rule out eight cycle completion rates less than 60%, within the statistical limitations of these small cohorts, the overall results for arms A and B are encouraging. Larger phase III studies are required to test these combinations

Interacting cosmic fluids in power-law Friedmann-Robertson-Walker cosmological models

We provide a detailed description for power--law scaling Friedmann-Robertson-Walker cosmological scenarios dominated by two interacting perfect fluid components during the expansion. As a consequence of the mutual interaction between the two fluids, neither component is conserved separately and the energy densities are proportional to $1/t^{2}$. It is shown that in flat FRW cosmological models there can exist interacting superpositions of two perfect fluids (each of them having a positive energy density) which accelerate the expansion of the universe. In this family there also exist flat power law cosmological scenarios where one of the fluids may have a ``cosmological constant" or "vacuum energy" equation of state ($p =-\rho$) interacting with the other component; this scenario exactly mimics the behavior of the standard flat Friedmann solution for a single fluid with a barotropic equation of state. These possibilities of combining interacting perfect fluids do not exist for the non-interacting mixtures of two perfect cosmic fluids, where the general solution for the scale factor is not described by power--law expressions and has a more complicated behavior. In this study is considered also the associated single fluid model interpretation for the interaction between two fluids.Comment: 10 pages. Accepted for publication in Physics Letters

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

A prospective, non-randomized, multicentre, open, dose-finding study of a carboplatin-docetaxel (C-D) combination as first-line chemotherapy in FIGO stage Ic–IV epithelial ovarian cancer. C-D was given 3-weekly for 6 planned cycles, with a 3-day prophylactic dexamethasone regimen (8 mg b.i.d.). 139 eligible patients (Pts) (median age 56 years, range 28–85) were given a total of 750 cycles of chemotherapy in 5 cohorts: Co1, 32 pts, 169 cycles (C at AUC 5 + D 60 mg/m2); Co2, 22 pts, 122 cycles (5 + 75), Co3, 29 pts, 156 cycles (6 + 75), Co4, 27 pts, 146 cycles (7 + 75), Co5, 30 pts, 157 cycles (6 + 85). 110 patients (79%) completed 6 cycles; 17 (12%) stopped due to toxicity. 104 patients (75%) had CTC grade IV neutropenia, and 5 patients (4%) had this associated with fever. There were 2 probable treatment-related deaths. Only 8 patients (6%) experienced grade II–III neurotoxicity (all sensory; no motor > grade I). The maximum tolerated dose was reached in cohorts 4 and 5, and the dose limiting toxicities were myelosuppression and diarrhoea. The overall response rate for the study was 66% (49/74); CA125 response was 75% (70/93). Median progression-free survival was 16.6 months (95% CI 13.3–19.1). Recommended doses are carboplatin AUC 5 (via51 Cr EDTA) or AUC 6 (if calculated) plus docetaxel 75 mg/m2. A randomized trial comparing this regimen with carboplatin-paclitaxel has just completed recruitment. © 2001 Cancer Research Campaign http://www.bjcancer.co